BIOCAD explained how artificial intelligence is helping to search for molecules for new drugs.
To develop an antibody-based drug, scientists need to select a molecule that will bind to the target protein in the body. Even a short 15 amino acid segment of an antibody has more than 30 quintillion possible sequences.
Neural networks offer options for a start. In the laboratory, scientists test how strongly the antibody binds to the target protein and whether it maintains its activity during storage.
Speeding up the search for promising early-stage molecules reduces overall development time and the time it takes to bring a drug to market.